On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet
Continue Reading Navigating the Haze of Cannabis Rules and Regulations in Europe

On August 19, 2019, the National Credit Union Administration (“NCUA”) made an economically significant change to the hemp banking landscape.  As is the case with cannabis businesses generally, hemp operations have faced considerable limitations with respect to access to traditional
Continue Reading Credit Unions Lending to Hemp-Related Businesses is Permissible